MVISX Mutual Fund

MVISX Mutual Fund

NAV$63.45
Do a full portfolio x-ray with MVISX
Just $25 once·$69/mo·Download sample
Get mine for $25

Fund Essentials - as of Mar 31, 2026

Net Assets
$7M
Expense Ratio
1.33%
Dividend Yield (Current)
0.17%
Holdings
36
Inception Date
Aug 22, 2018
Fund Family
Patient Capital Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+12.66%
1 Year+30.09%
3 Year+23.45%
5 Year+6.77%
10 Year+14.19%

Asset Allocation

Stocks: 94.30%
Other: 5.70%
Do a full portfolio x-ray with MVISX
$25 once. No subscription. Download sample.
Get mine for $25

Top Holdings

View All →
TickerNameWeight
RPD:DURoyalty Pharma Plc Class A Ordinary Share6.91%
CCitigroup Inc.6.54%
GOOGAlphabet Inc. C6.30%
QXOQxo, Inc.5.60%
AMZNAmazon.Com Inc5.46%
Top 10 Concentration: 53.42%Report Date: Mar 31, 2026
Download all 36 holdings for MVISX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.17%
Frequency
Annually
Latest Distribution
$0.04
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

MVISX Mutual Fund Overview

MVISX Mutual Fund (Patient Opportunity Trust Class IS) is managed by Patient Capital Management with $6.7M in net assets. MVISX expense ratio is 1.33%, holding 36 positions across sectors including Financials, Consumer Discretionary, Health Care. Inception date: 2018-08-22.

MVISX performance shows a YTD return of 12.66%. The 1-year return is 30.09% and the 5-year return is 6.77%. MVISX dividend yield stands at 0.17%, paid annually.

MVISX top holdings include Royalty Pharma Plc Class A Ordinary Share (6.9%), Citigroup Inc. (6.5%), Alphabet Inc. C (6.3%), Qxo, Inc. (5.6%), Amazon.Com Inc (5.5%). Go to all MVISX holdings, MVISX sectors, or MVISX dividends.

MVISX can be compared against other funds. Use MVISX overlap to find shared positions, or MVISX vs another fund for a side-by-side view. MVISX alternatives are available via the screener, along with tax-loss harvesting opportunities.